Who actually needs FISH testing ?

[Anonymous]

Who actually needs FISH testing — is it only used during pregnancy, or is it used for other conditions too?

[Genetic Counselor]

FISH is used across several distinct clinical situations, each sharing the same underlying logic: a specific genetic question already needs answering quickly or with confirmation.

• A pregnancy where a faster answer is needed. When an ultrasound finding, a screening test, or another concern raises the possibility of a common chromosome condition, such as an extra or missing copy of chromosome 13, 18, 21, X, or Y, this test can typically return a preliminary result within one to two days from a sample obtained through chorionic villus sampling or amniocentesis, well before a full chromosome analysis is complete. Because it only checks a handful of chromosomes, a normal result here is always followed by the complete analysis before major decisions are made.

• A child or adult whose features point to a specific microdeletion or microduplication syndrome. Some genetic conditions, such as 22q11.2 deletion syndrome, produce a recognizable combination of physical, heart, immune, and developmental features that lets a geneticist target one chromosome region directly, rather than scanning the whole genome first.

• A relative of someone with an already-identified chromosome change. Once a specific deletion, duplication, or rearrangement has been confirmed in one family member, this test can check parents, siblings, or other relatives for that exact same change quickly and at lower cost than repeating a full genome-wide test, which matters for understanding whether a change was inherited or arose newly, and for counselling about future pregnancies.

• Confirming a balanced chromosome rearrangement in a parent. When a couple has experienced recurrent pregnancy loss or a previous child with an unbalanced chromosome condition, this test can help characterize a parent’s rearrangement in detail once it has already been identified through a karyotype.

• Cancer diagnosis, prognosis, and treatment planning. Many cancers, particularly blood cancers such as leukemia and lymphoma, and certain solid tumors, are driven by a specific, well-characterized genetic change, such as two genes fusing together or extra copies of a particular gene. Testing tumor or bone marrow cells for these specific changes helps confirm a diagnosis, estimate prognosis, and, for some cancers, determine whether a targeted medication is likely to work.

Across all these situations, this test is chosen because the clinical picture has already narrowed the question down to one, or a small handful, of known possibilities, not because it is the best tool for an open-ended genetic search.

[Author]

Posts